Differential proteoglycan and hyaluronan distribution in calcified aortic valves
- 31 December 2011
- journal article
- Published by Elsevier BV in Cardiovascular Pathology
- Vol. 20 (6), 334-342
- https://doi.org/10.1016/j.carpath.2010.10.002
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Incidence and Progression of Aortic Valve Calcium in the Multi-Ethnic Study of Atherosclerosis (MESA)The American Journal of Cardiology, 2010
- Efficacy of Simvastatin Treatment of Valvular Interstitial Cells Varies With the Extracellular EnvironmentArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load and age: Relevance to an age-specific tissue-engineered heart valveActa Biomaterialia, 2008
- Dysregulation of Antioxidant Mechanisms Contributes to Increased Oxidative Stress in Calcific Aortic Valvular Stenosis in HumansJournal of the American College of Cardiology, 2008
- Increased levels of xylosyltransferase I correlate with the mineralization of the extracellular matrix during osteogenic differentiation of mesenchymal stem cellsMatrix Biology, 2008
- Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECMAtherosclerosis, 2007
- Distribution of SPARC during neovascularisation of degenerative aortic stenosisHeart, 2006
- An Ex Vivo Study of the Biological Properties of Porcine Aortic Valves in Response to Circumferential Cyclic StretchAnnals of Biomedical Engineering, 2006
- Paradoxical Effects of Statins on Aortic Valve Myofibroblasts and OsteoblastsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Loss of chondroitin 6‐sulfate and hyaluronan from failed porcine bioprosthetic valvesJournal of Biomedical Materials Research Part A, 2003